proteas
essenti
life
cycl
sever
acut
respiratori
syndromecoronaviru
sarscov
therefor
repres
key
antivir
target
compound
librari
consist
commerci
avail
drug
biolog
activ
substanc
screen
inhibit
sarscov
proteas
potent
inhibit
achiev
use
mercurycontain
compound
thimeros
phenylmercur
acet
well
hexachlorophen
well
lm
compound
inhibit
viral
replic
vero
cell
cultur
detail
mechan
studi
use
fluorescencebas
proteas
assay
demonstr
three
compound
act
competit
inhibitor
k
lm
phenylmercur
acet
thimeros
hexachlorophen
respect
panel
metal
ion
includ
zn
conjug
evalu
proteas
activ
inhibit
pronounc
use
zincconjug
compound
zinc
k
lm
use
ion
alon
k
lm
begin
guangdon
provinc
china
late
sever
acut
respiratori
syndrom
sar
caus
novel
human
coronaviru
cov
subsequ
spread
countri
subsequ
analysi
viru
reveal
featur
may
use
prevent
therapeut
strategi
analog
proteas
encod
picornavirus
viral
encod
proteas
function
matur
viral
polyprotein
essenti
complet
sarscov
life
cycl
chymotrypsinlik
proteas
use
cy
rather
ser
residu
nucleophil
activ
site
proteas
contain
addit
helic
ctermin
domain
residu
absent
analog
picornaviru
chymotrypsin
essenti
enzymat
activ
remov
obviat
proteolyt
activ
sinc
critic
domain
respons
dimer
proteas
prerequisit
proteolyt
activ
moreov
activ
site
sarscov
proteas
compris
catalyt
dyad
rather
triad
sarscov
proteas
repres
obviou
key
target
antisar
strategi
crystal
proteas
led
identif
sever
candid
inhibitor
comput
model
studi
biolog
assay
howev
date
detail
explor
inhibitor
activ
lack
previous
develop
fluorescencebas
assay
suitabl
screen
inhibitor
proteas
high
throughput
format
use
system
present
screen
compound
librari
consist
mostli
commerci
avail
drug
biolog
activ
substanc
light
previou
report
interest
examin
influenc
metalconjug
compound
proteas
activ
report
paper
sever
compound
inhibit
sarscov
proteas
includ
znconjug
compound
fluorogen
peptid
substrat
dabcylktsavlqsgfrkmeedan
sarscov
proteas
prepar
previous
report
proteas
store
buffer
contain
mm
trishcl
ph
mm
nacl
mm
edta
mm
bme
mm
dtt
use
compound
librari
obtain
genesi
plu
collect
microsourc
discoveri
system
inc
gaylordsvil
ct
mani
compound
collect
librari
compound
approv
unit
state
food
drug
administr
fda
abil
test
compound
inhibit
sarscov
replic
assay
use
vero
cell
cell
infect
sarscov
presenc
absenc
particular
test
compound
incub
two
day
atmospher
co
two
day
cell
harvest
lyse
equal
amount
cell
lysat
boil
sampl
load
buffer
mm
trishcl
ph
mm
dtt
sd
glycerol
bromophenol
blue
min
load
onto
sdspolyacrylamid
gel
electrophoresi
protein
transfer
onto
hybondc
extra
membran
use
semidri
apparatu
amersham
bioscienc
buckinghamshir
uk
membran
block
blotto
tween
block
buffer
mm
tri
ph
mm
nacl
tween
skim
milk
antiform
incub
balbc
antispik
polyclon
antibodi
membran
wash
block
buffer
incub
goat
antimous
hrpconjug
secondari
antibodi
membran
final
wash
block
buffer
develop
ecl
western
blot
detect
reagent
amersham
bioscienc
cell
viabil
determin
tetrazolium
salt
mt
assay
conduct
essenti
describ
conveni
method
base
convers
mt
chromat
solubl
formazan
live
cell
via
mitochondri
enzym
naddepend
dehydrogenas
mt
phenazin
methosulf
purchas
sigma
chemic
co
st
loui
mo
promega
madison
wi
powder
prepar
dulbecco
phosphatebuff
salin
measur
drug
concentr
perform
three
repeat
enhanc
fluoresc
due
proteolyt
catalyz
cleavag
dabcylktsavlqsgfrkmeedan
monitor
nm
excit
nm
use
fluoresc
plate
reader
fluoroskan
ascent
thermolabsystem
helsinki
finland
substrat
concentr
determin
extinct
coeffici
cm
nm
edan
cm
nm
dabcyl
fluorimetr
assay
util
identifi
inhibitor
sarscov
proteas
determin
inhibit
constant
k
measur
perform
two
fix
inhibitor
concentr
lm
lm
substrat
concentr
rang
lm
reaction
mixtur
contain
nm
sarscov
proteas
lineweaverburk
plot
kinet
data
fit
comput
program
kinetasyst
ii
intellikinet
state
colleg
pa
nonlinear
regress
obtain
k
valu
competit
noncompetit
inhibitor
use
eq
respect
equat
k
micha
constant
substrat
k
inhibit
constant
v
maxim
veloc
repres
inhibitor
substrat
concentr
reaction
mixtur
respect
compound
librari
contain
compound
screen
inhibit
sarscov
proteas
inhibit
result
applic
three
hit
phenylmercur
acet
thimeros
hexachlorophen
influenc
compound
viral
protein
product
indic
replic
examin
shown
western
blot
reveal
lm
phenylmercur
acet
suppress
detect
viral
spike
protein
fig
actin
level
vero
cell
treat
phenylmercur
acet
infect
sarscov
lower
indic
concentr
lm
compound
might
toxic
cell
presenc
lm
thimeros
diminish
detect
quantiti
spike
protein
percent
fig
similar
observ
obtain
use
lm
hexachlorophen
fig
latter
two
compound
display
appar
toxic
effect
evidenc
unchang
actin
level
hexachlorophen
concentr
also
show
strong
inhibit
cytopath
effect
virusinfect
vero
cell
result
shown
cytotox
exhibit
vero
cell
treat
lm
hexachlorophen
fig
determin
k
valu
phenylmercur
acet
thimeros
hexachlorophen
proteas
indic
compound
competit
inhibitor
k
valu
lm
phenylmercur
acet
lm
thimeros
lm
hexachlorophen
sinc
mercurycontain
compound
phenylmercur
acet
thimeros
may
pose
therapeut
hazard
patient
evalu
seri
metalcontain
compound
tabl
metal
ion
tabl
paramount
among
znconjug
compound
shown
fig
zinc
competit
inhibitor
k
valu
lm
contrast
zn
act
noncompetit
sarscov
proteas
larger
k
valu
lm
fig
indic
involv
organ
moieti
compound
inhibitori
activ
support
observ
nethylnphenyldithiocarbam
acid
zinc
zinc
show
similar
k
valu
lm
respect
zn
lm
wherea
zinc
markedli
smaller
k
lm
niclosamid
use
treatment
parasit
disord
show
promis
inhibitor
sarscov
replic
suggest
sarscov
proteas
inhibitor
basi
comput
model
howev
present
fluorimetr
assay
result
indic
inhibitori
effect
niclosamid
proteas
data
shown
present
studi
commer
avail
drug
biolog
activ
substanc
well
metalconjug
compound
test
abil
function
disrupt
sarscov
proteas
activ
proteas
prepar
dimer
function
form
activ
previous
prepar
proteas
virtu
absenc
extra
amino
acid
nand
ctermini
present
studi
involv
potent
enzym
enzym
activ
assess
realtim
use
fluorogen
substrat
examin
identifi
proteas
inhibit
compound
test
effect
compound
also
suppress
viral
replic
correl
antisarscov
proteas
activ
two
compound
phenylmercur
acet
thimeros
use
pharmaceut
excipi
wide
use
antimicrobi
preserv
parenter
topic
pharmaceut
formul
particular
phenylmercur
acet
use
antimocrobi
preserv
cosmet
bactericid
parenter
eyedrop
spermicid
anoth
effect
compound
hexachlorophen
antibacteri
compound
common
constitu
soap
scrub
experiment
use
cholinesteras
inhibitor
addit
antivir
activ
commerci
avail
compound
sever
metal
speci
display
potenti
sarscov
proteas
sever
metal
ion
inhibit
cy
proteas
via
interact
nucleophil
sulfur
anion
sarscov
proteas
also
cy
proteas
present
seven
transit
metal
ion
test
hg
zn
cu
effect
co
mg
mn
ni
inhibit
proteas
activ
metal
ion
noncompetit
inhibitor
virtu
size
small
block
substrat
bind
despit
capabl
interact
activ
site
cy
residu
phenylmercur
acet
phenylmercur
nitrat
similar
hg
inhibitori
power
howev
observ
markedli
higher
affin
zinc
proteas
compar
zn
consist
suggest
former
specif
inhibitor
noteworthi
zncontain
compound
zinc
acet
ad
supplement
drug
treatment
wilson
diseas
indic
safeti
ion
human
use
relevantli
zinc
salt
zincum
gluconicum
zenullos
may
effect
treat
common
cold
diseas
caus
rhinovirus
without
knowledg
molecular
target
thu
present
document
antisar
submicromolar
k
action
znconjug
compound
provid
firm
foundat
embark
upon
sar
therapeut
drug
explor
fig
k
measur
zinc
ion
reaction
veloc
sar
proteas
absenc
presenc
lm
j
zn
variou
substrat
concentr
rang
lm
use
determin
k
valu
lm
zn
fit
data
eq
use
kinetasyst
ii
program
inhibit
pattern
indic
zinc
ion
noncompetit
respect
substrat
fig
k
measur
select
sar
proteas
inhibitor
zinc
enzym
activ
measur
use
lm
fluorogen
substrat
absenc
presenc
lm
j
inhibitor
data
fit
eq
use
kinetasyst
ii
program
obtain
k
valu
lm
inhibit
pattern
indic
zinc
competit
respect
substrat
